Cerebrospinal fluid antibodies to tubulin are elevated in the patients with multiple sclerosis

European Journal of Neurology

Volumn 15, Issue 11, 2008, Pages 1173-1179

  Svarcova J ^a,b   Fialova L ^a   Bartos A ^c,d   Steinbachova M ^e   Malbohan, I ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^e Vidia Diagnostika Ltd   (Czech Republic)

Author keywords

Anti tubulin antibodies; Cerebrospinal fluid; ELISA; Multiple sclerosis; Tubulin

Indexed keywords

ANTIBODY; OCTAPEPTIDE; TUBULIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; TUBULIN; UP-REGULATION;

EID: 53549133659     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02223.x     Document Type: Article

References (23)

1. Downing KH. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics. Annual Review of Cell and Developmental Biology 2000 16 : 89 111.
2. McKean PG, Vaughan S, Gull K. The extended tubulin superfamily. Journal of Cell Science 2001 114 : 2723 2733.
3. Sullivan KF. Structure and utilization of tubulin isotypes. Annual Review of Cell Biology 1988 4 : 687 716.
4. Sullivan KF, Cleveland DW. Identification of conserved isotype-defining variable region sequences for four vertebrate beta tubulin polypeptide classes. Proceedings of the National Academy of Sciences of the United States of America 1986 83 : 4327 4331.
5. Lee MK, Rebhun LI, Frankfurter A. Posttranslational modification of class III beta-tubulin. Proceedings of the National Academy of Sciences of the United States of America 1990 87 : 7195 7199.
6. Burgoyne RD, Cambray-Deakin MA, Lewis SA, Sarkar S, Cowan NJ. Differential distribution of beta-tubulin isotypes in cerebellum. The EMBO Journal 1988 7 : 2311 2319.
7. Draberova E, Lukas Z, Ivanyi D, Viklicky V, Draber P. Expression of class III beta-tubulin in normal and neoplastic human tissues. Histochemistry and Cell Biology 1998 109 : 231 239.
8. Zaffaroni M. Biological indicators of the neurodegenerative phase of multiple sclerosis. Neurological Sciences 2003 24 (Suppl 5 S279 S282.
9. Couratier P, Yi FH, Preud'homme JL, et al. Serum autoantibodies to neurofilament proteins in sporadic amyotrophic lateral sclerosis. Journal of the Neurological Sciences 1998 154 : 137 145.
10. Bartos A, Fialova L, Soukupova J, Kukal J, Malbohan I, Pitha J. Antibodies against light neurofilaments in multiple sclerosis patients. Acta Neurologica Scandinavica 2007 116 : 100 107.
11. Bartos A, Fialova L, Soukupova J, Kukal J, Malbohan I, Pit'ha J. Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis. Journal of Neurology 2007 254 : 20 25.
12. Bornstein NM, Aronovich B, Korczyn AD, Shavit S, Michaelson DM, Chapman J. Antibodies to brain antigens following stroke. Neurology 2001 56 : 529 530.
13. Ehling R, Lutterotti A, Wanschitz J, et al. Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis. Multiple Sclerosis 2004 10 : 601 606.
14. Skoda D, Kranda K, Bojar M, et al. Antibody formation against beta-tubulin class III in response to brain trauma. Brain Research Bulletin 2006 68 : 213 216.
15. Skoda D, Hort J, Vyhnalek M, et al. Specific anti-beta tubulin antibodies in differential diagnosis of dementias. Czech and Slovac Neurology and Neurosurgery 2007 103 : 152 157.
16. Newcombe J, Gahan S, Cuzner ML. Serum antibodies against central nervous system proteins in human demyelinating disease. Clinical and Experimental Immunology 1985 59 : 383 390.
17. Silber E, Semra YK, Gregson NA, Sharief MK. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology 2002 58 : 1372 1381.
18. Terryberry JW, Thor G, Peter JB. Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis. Neurobiology of Aging 1998 19 : 205 216.
19. Stubbs EB Jr., Fisher MA, Siegel GJ. Anti-tubulin antibodies in a sensorimotor neuropathy patient alter tubulin polymerization. Acta Neuropathologica 1998 95 : 302 305.
20. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in multiple sclerosis. Neurology 1996 46 : 907 911.
21. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology 1983 13 : 227 231.
22. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology 2001 50 : 121 127.
23. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 33 : 1444 1452.